why choose us

Clinical Trials Search

Showing 8,790 of 132,656 result(s)
Concurrent vs. Sequential Cessation of Dual Cigarette and E-cigarette Use

Status: NOT_YET_RECRUITING

Condition: Cigarette Smoking

Interventions: Varenicline prescription will follow the standard induction period: varenicline 0.5 mg once per day for Days 1-3, varenicline 0.5 mg twice per day for

Date: 2023-08-30

Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency

Status: Completed

Condition: Ureter Injury

Interventions: Experimental contrast dye that is commonly used as a visualization aid in pelvic and abdominal surgeries and for various diagnostic procedures in medi

Date: 2023-08-30

Depression Return to Work Intervention

Status: Completed

Condition: Job Stress

Interventions: Participants will complete the six-week DRIVEN program, which includes a smartphone application and job coaching.

Date: 2023-08-30

The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults

Status: NOT_YET_RECRUITING

Condition: Frailty

Interventions: MitoQ given 20 mg per day for 12 weeks.

Date: 2023-08-30

Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan

Status: NOT_YET_RECRUITING

Condition: Acute Suicidal Depression (ASD)

Interventions: This trial will use standard dose of ketamine (0.5mg;kg infusion over 40 min period) in accordance with research studies that have used ketamine

Date: 2023-08-30

Positive Feedback vs. No-Feedback Games for Behavioral Change

Status: NOT_YET_RECRUITING

Condition: Major Depressive Disorder

Interventions: The positive feedback game uses techniques relating to established therapies like Behavioral Activation and Acceptance and Commitment Therapy's v

Date: 2023-08-30

Enlighten Study: The EV-ICD Post Approval Registry

Status: Completed

Condition: Ventricular Arrhythmia

Interventions: Device: Defibrillation using the Extravascular ICD (EV-ICD)

Date: 2023-08-30

Siplizumab for Sickle Cell Disease Transplant

Status: Completed

Condition: Anemia, Sickle Cell

Interventions: Premedication with diphenhydramine 50 mg PO is to be given 1 hour prior to siplizumab infusion.
Premedication with hydrocortisone succinate 100 m

Date: 2023-08-30

Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey

Status: Completed

Condition: Alzheimer Disease

Interventions: The PrecivityAD2 blood test measures plasma amyloid beta (A?) peptides 42 and 40 (A?42;40) Ratio and phosphorylated tau (p-tau) compared to non-p

Date: 2023-08-30